Request appointment
1 Gustave Levy PlaceNew York, NY 10029
Overview of Dr. Doroshow
Dr. Deborah Doroshow is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. She received her medical degree from Harvard Medical School and has been in practice 13 years. She is one of 187 doctors at The Mount Sinai Hospital and one of 66 doctors at Mount Sinai West who specialize in Oncology. She has more than 50 publications and over 500 citings.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2020- Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2015
Harvard Medical SchoolClass of 2013
Yale UniversityPh.D., History of Medicine, 2007 - 2012
Certifications & Licensure
NJ State Medical License 2022 - 2027
NY State Medical License 2019 - 2027
CT State Medical License 2015 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
- Pembrolizumab for Advanced NSCLC and PS 2-3 Start of enrollment: 2023 Dec 05
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.Deborah B Doroshow, Ticiana A Leal, Saiama N Waqar, Hossein Borghaei, D Ross Camidge
Journal of Clinical Oncology. 2026-06-03 - Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trial.Deborah B Doroshow, Geoffrey I Shapiro, Khanh Do, Vicki L Keedy, Haider Mahdi
Cancer. 2026-03-15 - Real-World Outcomes and Subsequent Treatment Patterns in Patients with Advanced Non-Small Cell Lung Cancer and Atypical EGFR Mutations Receiving First-Line Osimertinib...Jorge J Nieva, Xuejun Wang, Deborah Doroshow, Leslie Servidio, Miranda Cooper
Oncology and Therapy. 2026-03-01
Press Mentions
Mount Sinai Receives $4 Million Grant From American Cancer Society to Launch Cancer Health Research CenterAugust 11th, 2025- Appendix Cancers on the Rise in Younger Generations, Study FindsJune 9th, 2025
- ‘Are We Giving False Hope?’: Few Hospitalized People with Cancer Benefit from ImmunotherapyApril 7th, 2025
Grant Support
- TCI Early Career Cancer Clinical Investigator AwardICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2015–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
